Crohn's Disease and Colitis Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 18 and 75 years old.
- People who have a confirmed diagnosis of Ulcerative Colitis (UC), established through clinical assessment, a camera examination of the bowel (endoscopy), and tissue analysis.
- People whose UC is currently showing moderate to severe activity, confirmed by a bowel camera examination (colonoscopy) during the screening period.
- People who have never previously been treated with biologic medicines (such as infliximab, adalimumab, vedolizumab, or ustekinumab) or a type of medicine called JAK inhibitors.
- People who have not used steroid medicines taken by mouth or through a drip in the 4 weeks before the study start date.
- People who take mesalazine or 5-ASA medicines (by mouth or rectally), where the dose has remained unchanged for at least 2 weeks before the study start date.
- People who are willing and able to sign a written consent form agreeing to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have, or are strongly suspected of having, Crohn's disease, or other specific types of colitis such as ischemic, infectious, radiation-related, or tuberculosis-related colitis.
- People who have other conditions clearly causing bleeding from the bowel, such as active haemorrhoidal bleeding, bowel cancer, large bowel polyps larger than 1cm, or abnormal blood vessels in the bowel.
- People who have untreated medical conditions that may cause bowel bleeding, such as a very low platelet count or serious blood clotting problems.
- People who regularly use blood-thinning or anti-clotting medicines, such as aspirin, clopidogrel, warfarin, or rivaroxaban.
- People who are pregnant or currently breastfeeding.
- People who have any other medical condition that the trial doctor considers would make participation in the study unsafe or unsuitable (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18560089821
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite Endpoint Rate (Clinical Relapse OR Treatment Escalation)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.